West Pharmaceutical Services Cash Flow Statement
NYSE: WSTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
West Pharmaceutical Services free cash flow
In fiscal 2025, West Pharmaceutical Services generated $754.8 million of operating cash flow and spent $285.9 million on capital expenditures. That left free cash flow of $468.9 million, a free-cash-flow margin of 15.3% of revenue. Free cash flow was up 69.6% from the prior year's $276.4 million.
West Pharmaceutical Services returned $195.2 million to shareholders: $61.2 million in dividends and $134.0 million in share repurchases, equal to 42% of free cash flow. Free cash flow covered dividend payments 7.7 times.
Summary generated from market data by MetaCap's automated system. Methodology
West Pharmaceutical Services cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 493.70M | 492.70M | 593.40M | 585.90M | 661.80M | 346.20M | 241.70M | 206.90M | 150.70M | 143.60M |
| Net Income growth (YoY) | +0.20% | -16.97% | +1.28% | -11.47% | +91.16% | +43.24% | +16.82% | +37.29% | +4.94% | +50.21% |
| Depreciation & Amortization | 171.40M | 155.40M | 137.30M | 120.60M | 122.30M | 109.10M | 103.40M | 104.40M | 96.70M | 90.70M |
| Stock-Based Compensation | 23.80M | 18.70M | 23.30M | 23.70M | 37.50M | 34.00M | 24.40M | 15.10M | 16.10M | 19.50M |
| Change in Working Capital | -37.50M | -14.60M | -5.10M | -88.20M | -193.20M | -83.70M | -24.10M | -50.40M | -30.70M | -38.40M |
| Operating Cash Flow | 754.80M | 653.40M | 776.50M | 724.00M | 584.00M | 472.50M | 367.20M | 288.60M | 263.30M | 219.40M |
| Capital Expenditures | -285.90M | -377.00M | -362.00M | -284.60M | -253.40M | -174.40M | -126.40M | -104.70M | -130.80M | -170.20M |
| Investing Cash Flow | -285.90M | -378.70M | -368.70M | -288.20M | -253.10M | -179.50M | -228.00M | -100.80M | -133.60M | -175.80M |
| Dividends Paid | -61.20M | -59.10M | -57.00M | -54.10M | -51.10M | -48.10M | -45.10M | -42.10M | -39.10M | -35.80M |
| Share Repurchases | -134.00M | -560.90M | -438.30M | -202.80M | -137.10M | -115.50M | -83.10M | -70.80M | -74.40M | -52.20M |
| Debt Issued | 0 | 164.70M | 0 | 0 | — | — | — | — | — | — |
| Debt Repaid | 0 | -169.00M | -2.30M | -44.30M | 0 | 0 | -1.20M | 0 | -34.90M | -69.80M |
| Financing Cash Flow | -185.10M | -622.60M | -459.60M | -293.60M | -168.10M | -137.10M | -36.80M | -80.70M | -109.00M | -113.90M |
| Net Change in Cash | 306.70M | -369.30M | -40.40M | 131.70M | 147.10M | 176.40M | 101.70M | 101.50M | 32.90M | -71.60M |
| Free Cash Flow | 468.90M | 276.40M | 414.50M | 439.40M | 330.60M | 298.10M | 240.80M | 183.90M | 132.50M | 49.20M |
This table shows 10 annual periods of West Pharmaceutical Services's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow WST's reporting calendar. What is a cash flow statement?